Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and regadenoson

technetium tc 99m sestamibi has been researched along with regadenoson in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Bateman, TM; Blackburn, B; Cerqueira, MD; Hendel, RC; Iskandrian, AE; Leppo, JA; Mahmarian, JJ1
Belardinelli, L; Dione, DP; Jadbabaie, F; Mekkaoui, C; Meoli, DF; Purushothaman, K; Sinusas, AJ1
Dilsizian, V1
Berman, D; Brodov, Y; Fish, M; Gerlach, J; Germano, G; Gransar, H; Lemley, M; Otaki, Y; Rubeaux, M; Slomka, P1
Kerut, EK; Turner, MC1
Brice, LR; Farag, AA; Hage, FG; Iskandrian, AE; McRee, CW1
Corral, F; de la Fuente, C; Del Castillo, S; Fernandez-Vazquez, F; Garrote, C; Iglesias-Garriz, I; Lastra, JA; Rodríguez, E; Sevilla, A; Vara-Manso, J1

Trials

1 trial(s) available for technetium tc 99m sestamibi and regadenoson

ArticleYear
Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.
    Journal of the American College of Cardiology, 2005, Dec-06, Volume: 46, Issue:11

    Topics: Adenosine; Adenosine A2 Receptor Agonists; Electrocardiography; Heart; Humans; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Pilot Projects; Purines; Pyrazoles; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2005

Other Studies

6 other study(ies) available for technetium tc 99m sestamibi and regadenoson

ArticleYear
Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:10

    Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dogs; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2009
Connectivity of radiotracers to vasodilators is thallium the missing link?
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:10

    Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Dogs; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2009
Quantitation of left ventricular ejection fraction reserve from early gated regadenoson stress Tc-99m high-efficiency SPECT.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2016, Volume: 23, Issue:6

    Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Exercise Test; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left

2016
Coronary "balanced ischemia" with false negative regadenoson Technetium Tc99 m Sestamibi stress test subsequently diagnosed by FFR
    Echocardiography (Mount Kisco, N.Y.), 2018, Volume: 35, Issue:9

    Topics: Adenosine A2 Receptor Agonists; Computed Tomography Angiography; Coronary Angiography; Coronary Stenosis; Diagnosis, Differential; Exercise Test; False Negative Reactions; Female; Fractional Flow Reserve, Myocardial; Humans; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Stents; Technetium Tc 99m Sestamibi

2018
Evolution of symptoms in patients with stable angina after normal regadenoson myocardial perfusion imaging: The Radionuclide Imaging and Symptomatic Evolution study (RISE).
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:2

    Topics: Adult; Angina, Stable; Chest Pain; Female; Humans; Male; Myocardial Perfusion Imaging; Perfusion; Prognosis; Prospective Studies; Purines; Pyrazoles; Quality of Life; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2022
Diagnostic accuracy of regadenoson stress echocardiography: concordance with gated-spect myocardial perfusion imaging.
    The international journal of cardiovascular imaging, 2021, Volume: 37, Issue:2

    Topics: Aged; Cardiac-Gated Imaging Techniques; Comorbidity; Echocardiography, Stress; Female; Heart Disease Risk Factors; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Prevalence; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Smoking; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2021